Clinical Trial Update: The Effect of Nicotinamide on the Clinical Outcome of Rheumatoid Arthritis Patients [Phase 2]

View source ↗

Summary

An ongoing Phase 2 clinical trial evaluating nicotinamide for improving clinical outcomes in patients with rheumatoid arthritis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Nicotinamide (nicotinamide)

Snippet

Sponsor: Ain Shams University | Conditions: Rheumatoid Arthritis | Phase 2 | Status: RECRUITING